These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3979939)

  • 21. Treatment of metastatic sarcomas with mitoxantrone.
    Presant CA; Gams R; Bartolucci AA
    Cancer Treat Rep; 1984 May; 68(5):813-4. PubMed ID: 6722837
    [No Abstract]   [Full Text] [Related]  

  • 22. Mitoxantrone in malignant melanoma.
    Presant CA; Gams R; Bartolucci A
    Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent developments in chemotherapy of malignant diseases].
    Moser K; Pohl A
    Wien Klin Wochenschr; 1982 Dec; 94(23):640-8. PubMed ID: 6188282
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II trial of mitoxantrone in patients with primary liver cancer.
    Falkson G; Coetzer BJ; Terblanche AP
    Cancer Treat Rep; 1984 Oct; 68(10):1311-2. PubMed ID: 6525607
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 26. Mitoxantrone as first-line chemotherapy for advanced breast cancer: results of a European collaborative study.
    Smyth JF; Cornbleet MA; Stuart-Harris RC; Smith IE; Coleman RE; Rubens RD; McDonald M; Mouridsen HT; Rainer H; van Oosterom AT
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):15-8. PubMed ID: 6484578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitozantrone.
    Lancet; 1984 Aug; 2(8397):265-6. PubMed ID: 6146814
    [No Abstract]   [Full Text] [Related]  

  • 28. Potential cardiotoxicity with mitoxantrone.
    Schell FC; Yap HY; Blumenschein G; Valdivieso M; Bodey G
    Cancer Treat Rep; 1982 Aug; 66(8):1641-3. PubMed ID: 7105054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
    Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
    Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
    Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone.
    Lathan B; Von Hoff DD; Elslager E
    Cancer Treat Rep; 1984 May; 68(5):733-8. PubMed ID: 6233003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of mitoxantrone in refractory acute leukemia.
    Estey EH; Keating MJ; McCredie KB; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1983 Apr; 67(4):389-90. PubMed ID: 6850655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():57-63. PubMed ID: 6362878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
    Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract]   [Full Text] [Related]  

  • 35. Mitoxantrone: a replacement for doxorubicin?
    Conner CS
    Drug Intell Clin Pharm; 1984 Jun; 18(6):479-80. PubMed ID: 6734434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
    Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
    Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anti-tumor effects of adriamycin, 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on rat mammary cancer induced by 7,12-dimethyl benz (A) anthracene].
    Tominaga T; Kitamura M; Yoshida Y; Kosaki G
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1663-8. PubMed ID: 6433800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of mitozantrone.
    Birchall LA; Bailey NP; Blackledge GR
    Br J Clin Pract; 1991; 45(3):208-11. PubMed ID: 1805919
    [No Abstract]   [Full Text] [Related]  

  • 39. Mitoxantrone and cyclophosphamide in patients with advanced breast cancer.
    Ehninger G; Weible KH; Heidemann EG; Waller HD
    Cancer Treat Rep; 1984 Oct; 68(10):1283-4. PubMed ID: 6525600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial.
    Neidhart JA; Gochnour D; Roach RW; Steinberg JA; Young D
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():41-6. PubMed ID: 6362877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.